-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
New treatments for neurogenic detrusor overactivity
Gabriele Gaziev, Valerio Iacovelli, Luca Topazio, Daniele Bianchi & Enrico Finazzi Agro
Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Afatinib: rationale for use in non-small-cell lung cancer based on clinical trail data
Allan V Espinosa and Leora Horn
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
Long-term experience with biologic therapies for the treatment of polyarticular juvenile idiopathic arthritis
Ariane Klein, Gerd Horneff
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the diagnosis and treatment of axial spondyloarthritis
Pedro Machado, Robert Landewe, Desiree van der Heijde
Review: Clinical Trail Outcomes: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation
-
Improving the treatment outcome in follicular lymphoma using rituximab maintenance
Tadeusz Robak, Piotr Smolewski2
Editorial: Clinical Investigation